novavax inc (NVAX:NASDAQ GS)
Stanley C. Erck
Chief Executive Officer, President, Director and Member of Finance Committee, Novavax, Inc.
|Age||Total Calculated Compensation||This person is connected to 18 board members in 3 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Stanley C. Erck, also known as Stan, has been the Chief Executive Officer and President at Novavax, Inc. since April 2011. Mr. Erck served as the Chief Executive Officer and President of Intercell USA Inc. from May 2000 to 2008 and served as its Treasurer since May 2000. Mr. Erck has over 25 years of management experience in the healthcare and biotechnology industry to shepherd the development and commercialization of Iomai technology. He managed the process of developing ...
20 Firstfield RoadPhone: 240-268-2000
Gaithersburg, Maryland 20878
Board Members Memberships*
Former Chief Executive Officer, President, Treasurer and Director
Director and Chairman of Compensation Committee
Chief Executive Officer, President, Director and Member of Finance Committee
The University of Chicago
University of Illinois-Urbana-Champaign
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Anthony S. Marucci M.B.A.||Chief Executive Officer, President and Director|
Celldex Therapeutics, Inc.
|Jonathan J. Lewis M.D., Ph.D.||Chief Executive Officer and Director|
ZIOPHARM Oncology, Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|